샘플 요청 목록

 카트 문의
시장보고서
상품코드
1737275

세계의 승모판 질환 시장

Mitral Valve Diseases
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 384 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

승모판 질환 세계 시장은 2030년까지 47억 달러에 달할 전망

2024년에 31억 달러로 추정되는 승모판 질환 세계 시장은 2024-2030년 분석 기간 동안 CAGR 7.3%로 성장하여 2030년에는 47억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 승모판 수복 치료는 CAGR 9.2%를 기록하며 분석 기간 종료시에는 20억 달러에 달할 것으로 예측됩니다. 승모판 치환 치료 부문의 성장률은 분석 기간 CAGR로 5.8%로 추정됩니다.

미국 시장은 8억 3,480만 달러, 중국은 CAGR 11.7%로 성장 예측

미국의 승모판 질환 시장은 2024년에 8억 3,480만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 11.7%를 기록하며 2030년까지 10억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 3.5%와 7.1%로 예측됩니다. 유럽에서는 독일이 CAGR 4.8%로 성장할 것으로 예측됩니다.

세계의 승모판 질환 시장 - 주요 동향과 촉진요인 정리

승모판 질환이 전 세계 순환기 의학에서 중요한 초점이 되고 있는 이유는 무엇일까?

승모판막 폐쇄부전증(MR)과 승모판막 협착증(MS)을 포함한 승모판 질환은 전 세계 심혈관질환의 스펙트럼에서 큰 부담으로 작용하고 있습니다. 승모판막은 좌심방과 좌심실 사이에 위치하며 심장을 통과하는 한 방향의 혈류를 조절합니다. 이 판막에 구조적 또는 기능적 이상이 있으면 역류(누출) 또는 협착(협착)을 일으켜 결국 심박출량을 감소시키고 피로, 호흡곤란, 심계항진, 폐고혈압 등의 증상을 유발할 수 있습니다. 이러한 장애를 치료하지 않고 방치하면 울혈성 심부전으로 진행되어 사망 위험이 증가합니다.

고령화, 고혈압과 심방세동의 증가, 영상 진단의 향상으로 승모판 질환의 발견과 유병률 증가에 기여하고 있습니다. 선진국에서는 승모판막 일탈에 따른 퇴행성 MR이 더 흔하지만, 저소득 환경에서는 조기 치료 및 예방 의료에 대한 접근성이 제한되어 있어 류마티스성 승모판막 협착증이 여전히 심각한 문제입니다. 특히 최소침습적 수술과 경피적 카테터 삽입술 등 치료 옵션이 다양해짐에 따라 적시에 식별하고 관리하는 것이 임상적으로 더욱 중요해지고 있습니다.

진단 및 치료의 발전은 승모판막 장애의 치료 경로를 어떻게 형성하고 있는가?

경흉벽 심초음파, 경식도 심초음파, 3D 영상, 심장 MRI의 보급으로 승모판 질환의 진단 상황이 크게 개선되었습니다. 이러한 도구들은 판막의 해부학적 구조, 판막의 움직임, 판막의 크기, 판막실의 크기, 역류량을 정확하게 평가할 수 있어 질병의 조기 발견과 중증도 분류를 가능하게 합니다. 위험도 점수 시스템과 다변량 평가는 현재 치료 계획의 중심이 되어 경과 관찰, 약물 관리, 중재적 치료 중 어느 것을 선택할지 결정하는데 중요한 지침이 되고 있습니다.

중증 승모판 질환의 경우, 특히 심실 기능이 보존된 환자의 경우, 수술적 복원술이나 치환술이 오랫동안 표준 치료법으로 사용되어 왔습니다. 그러나 MitraClip, PASCAL, ViR/ViMAC 등 경카테터 승모판막 중재술(TMVI)의 혁신은 개복수술이 불가능한 고위험군 환자의 치료에 큰 변화를 가져오고 있습니다. 로봇 보조 수복술, 쇄골 치환 시스템, 고리형 링의 발전으로 시술의 안전성과 결과가 개선되고 있으며, 베타차단제, 이뇨제, 항응고제 등이 자주 사용되며, 초기 단계나 수술이 불가능한 환자의 증상 완화를 위한 약리학적 관리는 여전히 중요합니다.

어떤 환자 부문과 지역 시장이 가장 큰 영향을 받아 의료 수요를 주도하고 있는가?

승모판 질환은 특히 65세 이상의 고령자, 특히 당뇨병, 고혈압, 허혈성 심장질환 등 여러 합병증을 동반한 환자들에게 불균형적으로 영향을 미치며, MR은 평균 수명이 길고 퇴행성 질환이 지배적인 신흥 경제국에서 더 흔한 반면, 류마티스성 다발성 경화증은 아프리카, 남아시아, 라틴아메리카 일부 지역에서 젊은 인구에 영향을 미치고 있습니다. 라틴아메리카의 일부 지역에서는 젊은 연령층에서 계속 영향을 미치고 있습니다. 또한, 여성은 승모판막 탈출증으로 진단되는 빈도가 더 높으며, 나이가 들면서 역류로 진행될 가능성이 더 높습니다.

북미와 서유럽이 시장을 독점하고 있는 것은 잘 구축된 심혈관 인프라, 상환제도, 높은 진단 보급률에 기인합니다. 또한, 이들 지역은 TMVI 도입에 있어서도 선두를 달리고 있습니다. 아시아태평양은 인구 고령화, 치료 능력 향상, 구조적 심장 질환에 대한 인식 증가로 인해 수요가 증가하고 있습니다. 신흥 시장에서는 공중보건 캠페인, 이동형 진단 장비, 류마티스성 심장병 검진 등의 노력으로 의료 접근성을 높이는 데 기여하고 있습니다. 이러한 노력은 승모판 질환이 진행될 때까지 진단을 받지 못하는 경우가 많은 농촌 지역이나 의료 서비스가 부족한 지역에서 특히 중요합니다.

승모판 질환 세계 시장의 장기적인 성장을 주도하는 요인은 무엇인가?

승모판 질환 시장 성장의 원동력은 질병 이환율 증가, 영상 진단 및 중재술의 기술 발전, 임상 혁신과 인구통계학적 고령화 등이 복합적으로 작용하고 있습니다. 심부전 프로그램, 구조적 심장 클리닉, 다학제적 심장팀의 확대는 보다 신속하고 개인화된 치료 개입을 가능하게 하고 있으며, TMVI 장치에 대한 규제 당국의 승인과 보험 환급이 증가함에 따라 일차 및 이차 MR 사례에 대한 사용이 가속화되고 있습니다.

전 세계 임상시험을 통해 특히 심부전에 동반된 기능적 MR에 대한 조기 개입에 대한 증거가 늘어나고 있습니다. 또한, 경카테터 승모판막 치환술(TMVR) 장치의 개발로 해부학적으로 복잡한 환자나 이전에는 수술이 불가능했던 환자 치료에 새로운 지평을 열고 있습니다. 당일 퇴원 프로토콜, 실시간 모니터링, 원격 심전도 검사를 통한 후속 조치와 같은 환자 중심의 혁신은 장기적인 치료 제공을 개선하고 입원 비용을 절감하고 있습니다.

심장병학이 예방적, 최소침습적, 결과 중심 모델로 전환하는 가운데, 승모판 질환 관리는 삶의 질, 시술 안전성, 의료 경제성의 균형을 유지하면서 심혈관계 기술 혁신과 임상 투자의 핵심이 될 것입니다.

부문

치료 유형(승모판 수복술, 승모판 치환술, 심장재동기화치료, 승모판 치료제), 적응증(승모판 협착 증, 승모판 일탈증, 승모판 역류증), 최종사용자(병원, 외래 수술 센터, 기타 최종사용자)

조사 대상 기업 사례(총 합계 48개사)

  • 4C Medical Technologies
  • Abbott Laboratories
  • Affluent Medical
  • Anteris Technologies
  • Artivion, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cadrenal Therapeutics, Inc.
  • Colibri Heart Valve LLC
  • Corcym UK Limited
  • Edwards Lifesciences Corporation
  • HighLife Medical
  • Labcor Laboratorios Ltda
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Medtronic plc
  • Micro Interventional Devices, Inc.
  • Novartis AG
  • Zydus Lifesciences Limited

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 매출원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사하고 있습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월 : 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월 : 최종 관세 재설정

고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석:

미국 <> 중국 <> 멕시코 <> 캐나다 <> EU <> 일본 <> 인도 <> 기타 176개국

업계 최고의 이코노미스트 : Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트 그룹을 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정을 적용하고 있습니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.06.12

Global Mitral Valve Diseases Market to Reach US$4.7 Billion by 2030

The global market for Mitral Valve Diseases estimated at US$3.1 Billion in the year 2024, is expected to reach US$4.7 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Mitral Valve Repair Treatment, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Mitral Valve Replacement Treatment segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$834.8 Million While China is Forecast to Grow at 11.7% CAGR

The Mitral Valve Diseases market in the U.S. is estimated at US$834.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 11.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Mitral Valve Diseases Market - Key Trends & Drivers Summarized

Why Are Mitral Valve Diseases Emerging as a Critical Focus in Global Cardiovascular Care?

Mitral valve diseases, encompassing both mitral regurgitation (MR) and mitral stenosis (MS), represent a significant burden in the global spectrum of cardiovascular disorders. The mitral valve-situated between the left atrium and left ventricle-regulates unidirectional blood flow through the heart. Any structural or functional abnormalities in this valve can result in regurgitation (leakage) or stenosis (narrowing), ultimately impairing cardiac output and contributing to symptoms such as fatigue, dyspnea, palpitations, and pulmonary hypertension. Left untreated, these disorders progress to congestive heart failure and increased mortality risk.

Aging populations, rising rates of hypertension and atrial fibrillation, and improved imaging diagnostics are contributing to the increased detection and prevalence of mitral valve diseases. In developed countries, degenerative MR associated with mitral valve prolapse is more common, whereas in lower-income settings, rheumatic mitral stenosis remains a persistent issue due to limited access to early treatment and preventive care. The clinical importance of timely identification and management is growing, particularly with expanding therapeutic options that now include minimally invasive surgical and transcatheter procedures.

How Are Diagnostic and Therapeutic Advancements Reshaping the Treatment Pathway for Mitral Valve Disorders?

The diagnostic landscape for mitral valve diseases has significantly improved with the widespread availability of transthoracic and transesophageal echocardiography, 3D imaging, and cardiac MRI. These tools allow accurate assessment of valvular anatomy, leaflet motion, chamber dimensions, and regurgitant volume, enabling earlier detection and classification of disease severity. Risk scoring systems and multi-parametric evaluations are now central to treatment planning, guiding decisions between watchful waiting, pharmacologic management, and interventional therapy.

Surgical repair or replacement has long been the standard of care for severe mitral valve disease, particularly for patients with preserved ventricular function. However, innovations in transcatheter mitral valve interventions (TMVI), such as MitraClip, PASCAL, and valve-in-ring/valve-in-mitral annular calcification (ViR/ViMAC) procedures, are transforming treatment for high-risk patients who are not candidates for open surgery. Advances in robotic-assisted repair, chordal replacement systems, and annuloplasty rings are improving procedural safety and outcomes. Pharmacological management remains important in earlier stages or for symptomatic relief in non-operable patients, with beta-blockers, diuretics, and anticoagulants being frequently employed.

Which Patient Segments and Geographic Markets Are Most Affected and Driving Care Demand?

Mitral valve diseases disproportionately affect the elderly, particularly individuals above 65 years of age, many of whom present with multiple comorbidities such as diabetes, hypertension, or ischemic heart disease. MR is more prevalent in developed economies where life expectancy and degenerative diseases dominate, while rheumatic MS continues to impact younger populations in parts of Africa, South Asia, and Latin America. Additionally, women are more frequently diagnosed with mitral valve prolapse, which may progress to regurgitation in older age.

North America and Western Europe dominate the market due to well-established cardiovascular infrastructure, reimbursement mechanisms, and high diagnostic penetration. These regions are also leading in TMVI adoption. Asia-Pacific is witnessing growing demand due to aging demographics, increasing procedural capacity, and rising awareness of structural heart disease. In emerging markets, public health campaigns, mobile diagnostic units, and rheumatic heart disease screening initiatives are helping expand access to care. These efforts are especially important in rural and underserved regions, where mitral diseases often go undiagnosed until advanced stages.

What Is Driving Long-Term Growth in the Global Mitral Valve Diseases Market?

The growth in the mitral valve diseases market is driven by rising disease incidence, technological progress in imaging and intervention, and the convergence of clinical innovation with demographic aging. Expansion of heart failure programs, structural heart clinics, and multidisciplinary heart teams is allowing earlier and more personalized treatment interventions. Increasing regulatory approvals and reimbursement coverage for TMVI devices are accelerating their use in both primary and secondary MR cases.

Global clinical trials are expanding the evidence base for early intervention, particularly for functional MR associated with heart failure. Additionally, the development of transcatheter mitral valve replacement (TMVR) devices is unlocking new frontiers in treating anatomically complex or previously inoperable patients. Patient-centric innovations-including same-day discharge protocols, real-time monitoring, and telecardiology follow-ups-are improving long-term care delivery and reducing hospitalization costs.

As cardiology shifts toward preventative, less invasive, and outcomes-focused models, mitral valve disease management is set to remain a cornerstone of cardiovascular innovation and clinical investment-balancing quality of life, procedural safety, and healthcare economics.

SCOPE OF STUDY:

The report analyzes the Mitral Valve Diseases market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy, Mitral Valve Therapeutics); Indication (Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation); End-User (Hospitals, Ambulatory Surgery Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • 4C Medical Technologies
  • Abbott Laboratories
  • Affluent Medical
  • Anteris Technologies
  • Artivion, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cadrenal Therapeutics, Inc.
  • Colibri Heart Valve LLC
  • Corcym UK Limited
  • Edwards Lifesciences Corporation
  • HighLife Medical
  • Labcor Laboratorios Ltda
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Medtronic plc
  • Micro Interventional Devices, Inc.
  • Novartis AG
  • Zydus Lifesciences Limited

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Mitral Valve Diseases - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Degenerative and Functional Mitral Valve Diseases Drives Demand for Targeted Therapies
    • Expansion of Aging Global Population Throws the Spotlight on Age-Associated Mitral Regurgitation
    • Advancements in Non-Invasive Imaging Technologies Strengthen Early Diagnosis and Disease Monitoring
    • Growing Adoption of Minimally Invasive Valve Repair and Replacement Procedures Spurs Market Growth
    • Increased Use of Transcatheter Technologies Propels Innovation in Low-Risk Patient Interventions
    • Regulatory Approvals of TMVR Devices Accelerate Access to Novel Therapeutic Modalities
    • Integration of AI and 3D Echocardiography Enhances Accuracy in Mitral Valve Disease Assessment
    • Surge in Demand for Personalized Treatment Planning Drives Growth in Computational Modeling Applications
    • Rising Number of Structural Heart Disease Centers Expands Treatment Accessibility in Emerging Markets
    • Development of Next-Generation Annuloplasty Rings and Clip-Based Repair Devices Sustains Technological Advancements
    • Growing Clinical Evidence Supporting Valve-in-Valve and Valve-in-Ring Procedures Expands Physician Confidence
    • Collaborations Between Cardiology Societies and OEMs Strengthen Best Practice Guidelines for Intervention
    • Shifts Toward Early Intervention Strategies Propels Demand for Screening in Asymptomatic Populations
    • Global Growth in Cardiovascular Disease Awareness Campaigns Drives Preventive Diagnosis Efforts
    • Focus on Long-Term Outcomes and Patient-Reported Quality of Life Sustains Use of Durable Interventions
    • Increasing Investment in Regenerative Valve Research Opens New Frontiers for Biologic Therapies
    • Surge in High-Risk and Inoperable Patient Populations Fuels Demand for Transcatheter Access Routes
    • Improvements in Delivery System Profile and Device Flexibility Enhance Procedural Adoption
    • OEM Support for Surgeon Training and Clinical Education Accelerates Institutional Uptake
    • Reimbursement Expansion for Mitral Valve Procedures Drives Patient and Provider Willingness to Adopt
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mitral Valve Diseases Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mitral Valve Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Mitral Valve Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Mitral Valve Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Mitral Valve Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Mitral Valve Replacement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Mitral Valve Replacement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Mitral Valve Replacement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cardiac Resynchronization Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cardiac Resynchronization Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Mitral Valve Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Mitral Valve Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Mitral Valve Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Mitral Valve Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Mitral Valve Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Mitral Valve Stenosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Mitral Valve Prolapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Mitral Valve Prolapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Mitral Valve Prolapse by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Mitral Valve Regurgitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Mitral Valve Regurgitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Mitral Valve Regurgitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • JAPAN
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • CHINA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • EUROPE
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Mitral Valve Diseases by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • FRANCE
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • GERMANY
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Mitral Valve Diseases by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • INDIA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Mitral Valve Diseases by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Mitral Valve Diseases by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • AFRICA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제